Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Addiction. 2021 Jul 28;117(2):411–424. doi: 10.1111/add.15630

Figure 4.

Figure 4

Univariate sensitivity analysis showing the effect of various changes in parameter values or model assumptions (listed on left-hand side) on the incremental cost-effectiveness ratio (ICER, cost per DALY averted). The vertical line shows the base-case ICER per DALY averted. Numbers at the end of each bar are the new values used for each parameter, with grey bars giving the new ICER for decreases in parameters and black for increases in a parameter. The baseline cost of $5739 is the estimated total cost per individual treated in the intervention. DAA = direct-acting antivirals; DALY = disability-adjusted life-year; DOT = directly observed therapy; SVR = sustained virological response; TLC-IDU = test and linkage to care for injecting drug users